Case report: Resolution of VIPoma-related symptoms with peptide receptor radionuclide therapy

Case report: Resolution of VIPoma-related symptoms with peptide receptor radionuclide therapy

Peptide receptor radionuclide therapy (PRRT) is used for the management of neuroendocrine tumors (NETs) not responsive to somatostatin analogs. In this case series, we report two patients with pancreatic vasoactive intestinal peptide (VIP)-secreting NETs (VIPomas) not responsive to any other therapi...

Full description

Saved in:
Bibliographic Details
Main Authors: Turgut Bora Cengiz, Raksha Kulkarni, Virginia Corbett, Nasrin V. Ghesani, Edward Wolin, Munir V. Ghesani
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oncology
Subjects:
PRRT
VIPoma
inpatient PRRT
neuroendocrine tumor
pancreatic net
68Ga DOTATATE PET/CT
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1432758/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items